« Back
Home /
Amifostine trihydrate

Amifostine trihydrate

Item no.	TMO-T6381-200mg
Manufacturer	TargetMol
CASRN	112901-68-5
Amount	200 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 200 mg 25 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,98
Smiles	O.O.O.NCCCNCCSP(O)(O)=O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	WR2721 trihydrate
Similar products	112901-68-5
Shipping Condition	Cool pack
Available
Manufacturer - Targets	HIF/HIF Prolyl-Hydroxylase
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	268.27
Description	Amifostine trihydrate (WR2721) is the first approved radioprotective drug, used to decrease the risk of kidney problems caused by treatment with cisplatin.
Pathways	Metabolism\|\|\|Chromatin/Epigenetic

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T6381-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question